These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 21389676)

  • 61. High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxemic ALS patients suggest an abnormal response to hypoxia.
    Just N; Moreau C; Lassalle P; Gosset P; Perez T; Brunaud-Danel V; Wallaert B; Destée A; Defebvre L; Tonnel AB; Devos D
    Neuromuscul Disord; 2007 Feb; 17(2):169-73. PubMed ID: 17142042
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of hepatocyte growth factor in the skin of amyotrophic lateral sclerosis.
    Nomura M; Oketa Y; Yasui K; Ishikawa H; Ono S
    Acta Neurol Scand; 2012 Jun; 125(6):389-97. PubMed ID: 21824113
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study.
    Gagliardi D; Faravelli I; Meneri M; Saccomanno D; Govoni A; Magri F; Ricci G; Siciliano G; Pietro Comi G; Corti S
    J Cell Mol Med; 2021 Apr; 25(8):3765-3771. PubMed ID: 33609080
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Down regulation of trophic factors in neonatal rat spinal cord after administration of cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients.
    Deepa P; Shahani N; Alladi PA; Vijayalakshmi K; Sathyaprabha TN; Nalini A; Ravi V; Raju TR
    J Neural Transm (Vienna); 2011 Apr; 118(4):531-8. PubMed ID: 21069391
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Decrease in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in cerebrospinal fluid during elderly aging and in patients with sporadic form of amyotrophic lateral sclerosis.
    Isobe C; Abe T; Terayama Y
    Neurosignals; 2010; 18(1):43-8. PubMed ID: 20407287
    [TBL] [Abstract][Full Text] [Related]  

  • 66. VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo by activation of PI3-K pathway and inhibition of p38MAPK.
    Tovar-Y-Romo LB; Tapia R
    J Neurochem; 2010 Dec; 115(5):1090-101. PubMed ID: 20456006
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neurofilament phosphorylation is increased in ventral horn neurons of neonatal rat spinal cord exposed to cerebrospinal fluid from patients with amyotrophic lateral sclerosis.
    Rao MS; Devi MG; Nalini A; Shahani N; Raju TR
    Neurodegeneration; 1995 Dec; 4(4):397-401. PubMed ID: 8846233
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Amyotrophic lateral sclerosis: new developments in diagnostic markers.
    Dengler R; von Neuhoff N; Bufler J; Krampfl K; Peschel T; Grosskreutz J
    Neurodegener Dis; 2005; 2(3-4):177-84. PubMed ID: 16909023
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients.
    Gupta PK; Prabhakar S; Sharma S; Anand A
    J Neuroinflammation; 2011 May; 8():47. PubMed ID: 21569455
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration.
    Bilak MM; Corse AM; Bilak SR; Lehar M; Tombran-Tink J; Kuncl RW
    J Neuropathol Exp Neurol; 1999 Jul; 58(7):719-28. PubMed ID: 10411342
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CSF markers in amyotrophic lateral sclerosis.
    Tarasiuk J; Kułakowska A; Drozdowski W; Kornhuber J; Lewczuk P
    J Neural Transm (Vienna); 2012 Jul; 119(7):747-57. PubMed ID: 22555610
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia.
    Sun H; Bénardais K; Stanslowsky N; Thau-Habermann N; Hensel N; Huang D; Claus P; Dengler R; Stangel M; Petri S
    PLoS One; 2013; 8(9):e72926. PubMed ID: 24069165
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS).
    Niebroj-Dobosz I; Dziewulska D; Janik P
    Folia Neuropathol; 2006; 44(3):191-6. PubMed ID: 17039414
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
    Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
    Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quantitative studies of lower motor neuron degeneration in amyotrophic lateral sclerosis: evidence for exponential decay of motor unit numbers and greatest rate of loss at the site of onset.
    Baumann F; Henderson RD; Gareth Ridall P; Pettitt AN; McCombe PA
    Clin Neurophysiol; 2012 Oct; 123(10):2092-8. PubMed ID: 22520163
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cerebrospinal fluid cytotoxicity does not affect survival in amyotrophic lateral sclerosis.
    Galán L; Matías-Guiu J; Matias-Guiu JA; Yáñez M; Pytel V; Guerrero-Sola A; Vela-Souto A; Arranz-Tagarro JA; Gómez-Pinedo U; García AG
    Acta Neurol Scand; 2017 Sep; 136(3):212-216. PubMed ID: 28032330
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis.
    Roos PM; Vesterberg O; Syversen T; Flaten TP; Nordberg M
    Biol Trace Elem Res; 2013 Feb; 151(2):159-70. PubMed ID: 23225075
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis.
    Iłecka J
    J Neural Transm (Vienna); 2004 Feb; 111(2):167-72. PubMed ID: 14767719
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis.
    Gonçalves M; Tillack L; de Carvalho M; Pinto S; Conradt HS; Costa J
    Clin Chim Acta; 2015 Jan; 438():342-9. PubMed ID: 25261856
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
    Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
    Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.